Boston Scientific Corporation today welcomed the launch of a new website, www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Score™, a novel angiographic tool used to measure the complexity of coronary artery disease.
Boston Scientific
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Boston Scientific Corporation today announced the launch of the platinum chromium TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in select markets worldwide.
Boston Scientific to Donate Cardiac Rhythm Management Devices to Needy Patients
Boston Scientific Corporation today announced that it has agreed to donate Cardiac Rhythm Management devices to Heartbeat International, to implant in needy patients in countries outside the US.
Article Reports Fewer Repeat Procedures With Boston Scientific’s TAXUS® Liberte® Stent
Journal of American College of Cardiology reports fewer repeat procedures with Boston Scientific’s TAXUS® Liberte® Paclitaxel-Eluting Stent compared to patients treated with ‘olimus-based drug-eluting stents.
Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent
Boston Scientific Corporation announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company’s stent litigation with Johnson and Johnson.
NovaLign nabs FDA approval for bone fixation system
NovaLign Orthopedics Inc. can now market its first product, a bone fixation system, after it received clearance from the Food and Drug Administration.
Boston Scientific Launches New Coronary Imaging Catheter
Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the deliverability of the Company’s market-leading intravascular ultrasound (IVUS) technology, the iLab® Ultrasound Imaging System.
OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific
OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of vascular diseases, today announced that it has filed a lawsuit against Boston Scientific Corporation.
Boston Scientific Announces Election Of John Sununu To Its Board Of Directors
Boston Scientific Corporation today announced that the Company’s Board of Directors has elected John E. Sununu as a Director.
Boston Scientific and Medtronic Reach Agreement on Patent Disputes
Agreement stops all litigation in interventional cardiology and endovascular repair.
Boston Scientific Announces Court Decision
Boston Scientific Corporation has announced a decision by the United States District Court in Delaware regarding a patent owned by Johnson & Johnson and Boston Scientific’s NIR® stent product
Boston Scientific to Participate in UBS Global Life Sciences Conference
Boston Scientific Corporation is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22 … continue reading “Boston Scientific to Participate in UBS Global Life Sciences Conference”
Medtronic awarded $250m damages in patent pcase
A federal jury found that Boston Scientific has infringed three patents owned by Medtronic